tradingkey.logo

Pfizer Announces Positive Results From Breakwater Trial Cohort 3

ReutersJan 10, 2026 3:01 PM

- Pfizer Inc PFE.N:

  • PFIZER'S BRAFTOVI® REGIMEN WITH ADDITIONAL CHEMOTHERAPY BACKBONE INCREASED RESPONSE RATES FOR CERTAIN PATIENTS WITH METASTATIC COLORECTAL CANCER

  • PFIZER - ANNOUNCES POSITIVE RESULTS FROM BREAKWATER TRIAL COHORT 3

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI